Dr. Daniel R. Bensimhon and Dr. C. Michael Gibson Discuss: Novel Bumetanide Nasal Spray (BNS) Demonstrates Safety, Tolerability and Equivalent Efficacy Compared to Intravenous and Oral Bumetanide (RSQ-777-02)
Disclosures: TBD
Clinical Trial Results
Disclosures: TBD